Cohort studycited by the Tayebat archiveabstract only checked A-UPF-19 standard review

Artificial sweeteners and heart disease in France

Artificial sweeteners and risk of cardiovascular diseases: results from the prospective NutriNet-Santé cohort.

Overview

Debras C et al.. BMJ 2022 · PMID 36638072 · DOI 10.1136/bmj-2022-071204

Higher sweetener intake: 9% higher cardiovascular risk.

Does the study support the specific claim? Partly · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Are artificial sweeteners associated with CVD?

How was the study done?

Prospective cohort with repeated 24-h records.

How many people, animals or samples were studied?

103,388; 1,502 CVD events; Adults, 79.8% women

What was actually found?

Total sweeteners CVD HR 1.09 (1.01-1.18); cerebrovascular 1.18 (1.06-1.31); aspartame cerebrovascular 1.17 (1.03-1.33); acesulfame-K CHD 1.40 (1.06-1.84); sucralose CHD 1.31 (1.00-1.71).

How large was the observed effect?

HR 1.09 (1.01-1.18)

What do the results mean in everyday life?

Small possible signal.

What are the study's limitations?

Reverse causation; Residual confounding

What does it say about Elawady's specific claim?

Mixed for C-UPF-07.

Do the results apply to Germany and Europe?

High.

What can explicitly not be concluded from this study?

Causation.

Scientific in-depth review

1. Full reference

Authors
Debras C, Chazelas E, Sellem L, Porcher R, Druesne-Pecollo N, Esseddik Y, de Edelenyi FS, Agaësse C, De Sa A, Lutchia R, Fezeu LK, Julia C, Kesse-Guyot E, Allès B, Galan P, Hercberg S, Deschasaux-Tanguy M, Huybrechts I, Srour B, Touvier M
Journal
BMJ
Year
2022
Identifier
PMID 36638072 DOI 10.1136/bmj-2022-071204 · PMC9449855
Verification
verified – PubMed E-utilities efetch, 2026-10-25
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Public funding declared; WHO grant

2. Research question

Are artificial sweeteners associated with CVD?

3. Study design and population

Study design
Cohort study – Prospective cohort with repeated 24-h records.
Population

Adults, 79.8% women

Country

France

Period

2009-2021

Sample size

103,388; 1,502 CVD events

Inclusion and exclusion criteria

not stated in abstract

4. Methods and endpoints

Exposure / intervention

Sweetener intake (log10 continuous)

Comparator

Non-consumers

Endpoints

CVD, CHD, cerebrovascular

Statistical methods

Cox

5. Actual results

Results

Total sweeteners CVD HR 1.09 (1.01-1.18); cerebrovascular 1.18 (1.06-1.31); aspartame cerebrovascular 1.17 (1.03-1.33); acesulfame-K CHD 1.40 (1.06-1.84); sucralose CHD 1.31 (1.00-1.71).

Absolute risks

CVD 346 vs 314 per 100,000 PY (higher vs non-consumers)

Authors' conclusion

Suggests potential association between higher sweetener intake and CVD.

6. Strengths

  • Large; detailed exposure

7. Weaknesses

  • Reverse causation
  • Residual confounding

8. Risk of bias

Orienting tool
ROBINS-E
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Confounding.

9. Assessment of the statistical interpretation

Small absolute differences.

10. Relevance to the specific claim

Mixed for C-UPF-07.

11. Independent contrary findings

I-SOD-09.

12. Transferability to Germany and Europe

High.

13. Overall methodological judgement

Signal.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultsmoderate
Directnessdirect
Reproducibilitynot replicated
Consistency with the overall evidenceunknown
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

Causality.

15. Linked fact checks

Use by the Tayebat archive

Note: according to the archive, the studies were compiled by the archive operators. Whether Dr. Elawady himself cited this study is not established.

What the archive says about the study

Listed in the archive bibliography only (no archive interpretation card).

A. What was actually studied?

Sweeteners and CVD.

B. What did the authors find?

As above.

C. What conclusions do the authors themselves draw?

Potential association.

D. What does the archive derive from it?

Supports sweetener harm.

E. Is this derivation scientifically justified?

Association only.

Adequacy of the interpretation (by the archive)
not applicable